STEP-1 PumEtch is a prophylaxis and phosphoric acid etchant treatment intended for the smface preparation of dentin or enamel prior to tooth restoration, including the application of sealants or for bonding.
Device Story
STEP-1 PumEtch is a dental preparation agent combining 37% phosphoric acid etchant and pumice polishing agent in a single gel-liquid solution. Used by dental professionals in clinical settings to prepare natural tooth surfaces (dentin/enamel) before applying sealants or direct bond appliances. The device functions by simultaneously cleaning and etching the tooth surface to facilitate bonding. It is applied directly to the tooth; the healthcare provider uses the resulting surface preparation to improve the adhesion of subsequent restorative materials. The device benefits patients by streamlining the preparation process into a single step.
Clinical Evidence
Bench testing only. Comparative performance testing for Shear Bond Strength (SBS) and pH demonstrated no statistically significant difference between the subject and predicate devices.
Technological Characteristics
Formulation: 37% phosphoric acid and pumice in a gel-liquid solution. Includes xanthan gum as a thickening agent. Class II dental resin tooth bonding agent.
Indications for Use
Indicated for surface preparation of dentin or enamel prior to tooth restoration, sealant application, or bonding in patients requiring dental prophylaxis and acid etching.
Regulatory Classification
Identification
A resin tooth bonding agent is a device material, such as methylmethacrylate, intended to be painted on the interior of a prepared cavity of a tooth to improve retention of a restoration, such as a filling.
K152110 — e-1 etchants · E Dental Products · Nov 20, 2015
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The FDA logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA acronym along with the full name of the agency on the right. The Department of Health & Human Services logo features a stylized human figure, while the FDA part includes the acronym "FDA" in a blue square, followed by "U.S. FOOD & DRUG" and "ADMINISTRATION" in blue text.
January 28, 2022
Rounding Third LLC Adrienne Foller Regulatory Consultant ORS Solutions LLC 966 E. 2050 N North Ogden. Utah 84414
Re: K213093
Trade/Device Name: STEP-1 PumEtch Regulation Number: 21 CFR 872.3200 Regulation Name: Resin Tooth Bonding Agent Regulatory Class: Class II Product Code: KLE, EJR Dated: November 29, 2021 Received: December 1, 2021
Dear Adrienne Foller:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
{1}------------------------------------------------
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Michael E. Adjodha, M.ChE. Assistant Director DHT1B: Division of Dental and ENT Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
## Indications for Use
510(k) Number (if known) K213093
Device Name STEP-1 PumEtch
#### Indications for Use (Describe)
STEP-I PumEtch is a prophylaxis and phosphoric acid etchant treatment intended for the smface preparation of dentin or enamel prior to tooth restoration, including the application of sealants or for bonding.
| Type of Use (Select one or both, as applicable) | |
|-----------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------|
| <span style="font-family: Arial;">☑</span> Prescription Use (Part 21 CFR 801 Subpart D) | <span style="font-family: Arial;">☐</span> Over-The-Counter Use (21 CFR 801 Subpart C) |
#### CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
# Section 5
K213093
# 510(k) Summary
| Name of Sponsor: | Smile Stream, LLC<br>9750 East Easter Avenue, #155<br>Centennial, CO 80112 |
|-----------------------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| 510(k) Contact: | Adrienne von Foller<br>Regulatory Affairs Consultant<br>QRS Solutions, LLC<br>Telephone: (801) 916-8188<br>AVonFoller@qrssolutionsllc.com |
| Date Prepared: | 29 November 2021 |
| Submission Type: | Traditional 510(k) |
| Proprietary Name: | STEP-1 PumEtch |
| Common Name: | Resin tooth bonding agent |
| Classification: | 21 CFR 872.3200 |
| Device Class: | Class II |
| Device Product Code: | KLE, EJR |
| Predicate Device: | Premier Etch |
| 510(k) Applicant: | Premier Dental Company Products |
| 510(k): | K141839 |
| Primary Reference Device: | Enamel Pro |
| 510(k) Applicant: | Premier Dental Company Products |
| 510(k): | K062166 |
| Secondary Reference Device: | DiaEtch |
| 510(k) Applicant: | DiaDent Group International |
| 510(k): | K192273 |
### 5.1 Device Description
STEP-1 PumEtch is a tooth preparation formulation combining a 37% phosphoric acid etch and pumice, a polishing agent, into one gel liquid solution. The product is used to prepare natural tooth surfaces for the application of sealants or direct bond appliances.
{4}------------------------------------------------
### 5.2 Indications for Use
STEP-1 PumEtch is a prophylaxis and phosphoric acid etchant treatment intended for the surface preparation of dentin or enamel prior to tooth restoration, including the application of sealants or for bonding.
### 5.3 Basis for Substantial Equivalence:
STEP-1 PumEtch has the same technological characteristics as the predicate device, including:
- 1. Indications for use
- 2. Intended use
- 3. Basic principles of operation
- 4. Basic formula
The following comparative performance testing was conducted which demonstrated there is no statistically significant difference between the subject and predicate devices.
- Shear Bond Strength (SBS)
- . pH
The fundamental scientific technology of STEP-1 PumEtch is the same as the previously cleared predicate device. No animal or clinical studies were deemed necessary for a determination of substantial equivalence.
The intended use of the subject device is the same as the predicate device. Based on similarities in indications for use, basic design, and the principle of operation, the STEP-1 PumEtch is substantially equivalent to the previously cleared predicate device.
A primary reference device has been included to support the safety and common use of pumice as a dental prophylaxis. A secondary reference device has been included to support the safety and common use of xanthan gum as a thickening agent in a dental etchant. However, substantial equivalence of the subject device to the reference devices is not required.
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.